June 22, 2024Open Access
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT
Key Points
Key points are not available for this paper at this time.
Abstract
To evaluate the cardiovascular effects of semaglutide by baseline glycated hemoglobin (HbA1c) and change in HbA1c in a prespecified analysis of Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT).
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
I
Ildiko Lingvay
Parkland Health & Hospital System
John Deanfield
University College London
Steven E. Kahn
Kagoshima University
Journals
Diabetes Care
Actions
Institutions
Harvard University
University of Washington
Centre National de la Recherche Scientifique
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...